Modern Chinese Medicine Group Co., Ltd.

Equities

1643

KYG6181B1068

Pharmaceuticals

Market Closed - Hong Kong S.E. 04:08:20 2024-04-26 am EDT 5-day change 1st Jan Change
0.3 HKD -1.64% Intraday chart for Modern Chinese Medicine Group Co., Ltd. -6.25% -11.76%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Modern Chinese Medicine Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Modern Chinese Medicine Warns of Up to 48% Profit Slump MT
Modern Chinese Medicine Group Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023 CI
Modern Chinese Medicine Arm Awards 121 Million Engineering Contract MT
Modern Chinese Medicine Group Co., Ltd. Announces Director Changes and Change in Composition of the Nomination Committee CI
Modern Chinese Medicine Group Co., Ltd. Announces Management Changes CI
Modern Chinese Medicine Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Modern Chinese Medicine's Profit to Drop Up to 50% in H1; Shares Drop 5% MT
Modern Chinese Medicine Group Co., Ltd. Provides Preliminary Unaudited Consolidated Group Earnings Guidance for the Six Months 30 June 2023 CI
Modern Chinese Medicine Group Co., Ltd. Announces Change of Principal Place of Business in Hong Kong CI
Modern Chinese Medicine Group Co., Ltd. Announces Executive Changes CI
Modern Chinese Medicine Group Co., Ltd. Do Not Recommend the Payment of Final Dividend for the Year Ended 31 December 2022 CI
Modern Chinese Medicine Group Co., Ltd. Announces Board Changes CI
Modern Chinese Medicine Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Bai Hua Cun Pharma Tech Unit Raises Capital by 90 Million Yuan MT
Modern Chinese Medicine Posts Rise in H1 Net Profit MT
Modern Chinese Medicine Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Modern Chinese Medicine Group Co., Ltd. Announces Change of Address of Principal Place of Business in Hong Kong, with Effect from August 15, 2022 CI
Modern Chinese Medicine Group Co., Ltd. Approves Final Dividend for the Year Ended 31 December 2021 CI
Modern Chinese Medicine's Per-Share Earnings Slip on Higher Expenses in 2021 MT
Modern Chinese Medicine Group Co., Ltd. Recommends Final Dividend for the Year Ended 31 December 2021, Payable on 13 June 2022 CI
Modern Chinese Medicine Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Certain Ordinary Shares of Modern Chinese Medicine Group Co., Ltd. are subject to a Lock-Up Agreement Ending on 14-JAN-2022. CI
Modern Chinese Medicine Chairman Passes Away MT
Modern Chinese Medicine Group Co., Ltd. Announces Demise of Xie Wei, Chairman of the Board and Executive Director CI
Chart Modern Chinese Medicine Group Co., Ltd.
More charts
Modern Chinese Medicine Group Co Ltd is a China-based investment holding company that mainly produces Chinese patent medicines. The Company mainly provides over-the-counter (OTC) and prescribed medicine intended for use by the middle-aged and elderly people. The Company's main products are Vigour and Vitality Supplement Pill, Circulation Enhancement Pill, Cardiotonic Enhancement Capsule, Kidney Invigoration Pill, Heart Wellness Capsule, Menstrual Discomfort Relief Pill, Liver Detox Tablet, Additional Ingredient Huoxiang ZhengQi Pill and Fever-removing and Detoxremoving Pill. The Company is also engaged in the production of other traditional Chinese medicines designed to treat or relieve other conditions such as psychological, respiratory, and pediatric conditions. The Company mainly conducts business within the domestic market.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 1643 Stock
  4. News Modern Chinese Medicine Group Co., Ltd.
  5. Modern Chinese Medicine Warns of Up to 48% Profit Slump